检索结果 - Robert T. Heelan
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma 由 Nael Martini, Robert T. Heelan, Jack Westcott, Manjit S. Bains, Patricia McCormack, James F. Caravelli, Robin C. Watson, Muhammad Zaman
出版 1985Artigo -
4
-
5
Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II Trial 由 Raja M. Flores, Lee M. Krug, Kenneth E. Rosenzweig, Ennapadam Venkatraman, A. Vincent, Robert T. Heelan, Tim Akhurst, Valerie W. Rusch
出版 2006Artigo -
6
-
7
-
8
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer 由 Vincent A. Miller, James R. Rigas, Prudence A. Francis, Stefan C. Grant, Katherine M.W. Pisters, Mark G. Kris, Karen Woolley, Ennapadam Venkatraman, Robert T. Heelan
出版 1995Artigo -
9
-
10
A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancer 由 Daniel T. Milton, Christopher G. Azzoli, Robert T. Heelan, Ennapadam Venkatraman, Jorge Gómez, Mark G. Kris, Lee M. Krug, William Pao, Naiyer A. Rizvi, Megan Dunne, Vincent A. Miller
出版 2006Artigo -
11
-
12
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer 由 Daniel T. Milton, Gregory J. Riely, Christopher G. Azzoli, Jorge Gómez, Robert T. Heelan, Mark G. Kris, Lee M. Krug, William Pao, Barbara Pizzo, Naiyer A. Rizvi, Vincent A. Miller
出版 2007Artigo -
13
Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non–Small-Cell Lung Cancer 由 Naiyer A. Rizvi, Gregory J. Riely, Christopher G. Azzoli, Vincent A. Miller, Kenneth Ng, John J. Fiore, Gloria Chia, Martin Brower, Robert T. Heelan, Michael Hawkins, Mark G. Kris
出版 2008Artigo -
14
-
15
-
16
Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients 由 Nael Martini, Mark G. Kris, Betty J. Flehinger, Richard J. Gralla, Manjit S. Bains, Michael Burt, Robert T. Heelan, Patricia McCormack, Katherine M.W. Pisters, James R. Rigas, Valerie W. Rusch, Robert J. Ginsberg
出版 1993Artigo -
17
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma 由 Lee M. Krug, Vincent A. Miller, Jyoti D. Patel, John P. Crapanzano, Christopher G. Azzoli, Jorge Gómez, Mark G. Kris, Robert T. Heelan, Barbara Pizzo, Leslie B. Tyson, Christine E. Sheehan, Jeffrey S. Ross, Ennapadam Venkatraman
出版 2005Artigo -
18
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer 由 Carolyn E. Reed, David H. Harpole, Katherine E. Posther, Sandra Woolson, Robert J. Downey, Bryan F. Meyers, Robert T. Heelan, Homer A. Macapinlac, Sin‐Ho Jung, Gerard A. Silvestri, Barry A. Siegel, Valerie W. Rusch
出版 2003Artigo -
19
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib 由 William Pao, Vincent A. Miller, Maureen F. Zakowski, Jennifer A. Doherty, Katerina Politi, Inderpal S. Sarkaria, Bhuvanesh Singh, Robert T. Heelan, Valerie W. Rusch, Lucinda A. Fulton, Elaine R. Mardis, Doris M. Kupfer, Richard K. Wilson, Mark G. Kris, Harold Varmus
出版 2004Artigo -
20
Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutatio... 由 Naiyer A. Rizvi, Valerie W. Rusch, William Pao, Jamie E. Chaft, Marc Ladanyi, Vincent A. Miller, Lee M. Krug, Christopher G. Azzoli, Manjit S. Bains, Robert J. Downey, Raja M. Flores, Bernard J. Park, Bhuvanesh Singh, Maureen F. Zakowski, Robert T. Heelan, Ronglai Shen, Mark G. Kris
出版 2011Artigo
相关主题
Medicine
Internal medicine
Lung cancer
Cancer
Oncology
Chemotherapy
Epidermal growth factor receptor
Pathology
Surgery
Gefitinib
Radiology
Biology
Adenocarcinoma
Lung
Gastroenterology
Mediastinum
Phases of clinical research
Cancer research
Colorectal cancer
Docetaxel
Erlotinib
KRAS
Paleontology
Rash
Stage (stratigraphy)
Tyrosine-kinase inhibitor
Breast cancer
Carcinoma
Everolimus
Febrile neutropenia